Modere, a maker of nontoxic personal-care products, has assembled a Scientific Advisory Board to support product development and innovation.
Initially, the Utah-based company has named five board members, whose combined professional experience amounts to more than 150 years. Together they hold more than 50 medical patents. These third-party advisors will help to guide Modere’s research and development efforts, in keeping with the company’s “live clean” promise, a commitment to avoid about 3,000 potentially harmful ingredients in its product formulations.
Modere’s newly appointed Scientific Advisory Board includes Robert A. Harper, Ph.D., a biochemist with expertise in toxicology of the skin and a member of the American Academy of Dermatology; Wallace Hayes, Ph.D., a professor of toxicology at Michigan State University and Harvard University who has published more than 250 peer-reviewed papers; Edison Miyawaki, M.D., a specialist in psychiatry and neurology who has taught on the subjects for more than 30 years; and Tracy Cornuelle, Ph.D., who has 20-plus years of product development experience and currently works in R&D at Modere.
A final advisor, Greg Horn, also is the formulator of Modere’s M3 weight-loss system, which was developed around the Mediterranean lifestyle. Horn is known for his track record on the commercial side of health and nutrition, having formerly served as CEO of Garden of Life, a top natural supplement brand, and of GNC, the world’s largest specialty retailer of nutrition products, which added revenue of $100 million per year—for 11 consecutive years—during his tenure in management. He is now CEO of Specialty Nutrition Group, a nutrition consultancy focused on commercializing IP-protected nutritional and health-promoting technologies.